- Home
- EVOK vs KXIN Comparison
EVOK vs KXIN Comparison
Compare EVOK & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- KXIN
- Stock Information
- Founded
- EVOK 2007
- KXIN 2015
- Country
- EVOK United States
- KXIN China
- Employees
- EVOK N/A
- KXIN N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- EVOK Health Care
- KXIN Consumer Discretionary
- Exchange
- EVOK Nasdaq
- KXIN Nasdaq
- Market Cap
- EVOK 18.4M
- KXIN 16.9M
- IPO Year
- EVOK 2013
- KXIN N/A
- Fundamental
- Price
- EVOK $10.85
- KXIN $0.20
- Analyst Decision
- EVOK
- KXIN
- Analyst Count
- EVOK 0
- KXIN 0
- Target Price
- EVOK N/A
- KXIN N/A
- AVG Volume (30 Days)
- EVOK 246.8K
- KXIN 21.7M
- Earning Date
- EVOK 11-13-2025
- KXIN 01-01-0001
- Dividend Yield
- EVOK N/A
- KXIN N/A
- EPS Growth
- EVOK N/A
- KXIN N/A
- EPS
- EVOK N/A
- KXIN N/A
- Revenue
- EVOK $14,424,652.00
- KXIN $95,000.00
- Revenue This Year
- EVOK $57.38
- KXIN N/A
- Revenue Next Year
- EVOK $59.57
- KXIN N/A
- P/E Ratio
- EVOK N/A
- KXIN N/A
- Revenue Growth
- EVOK 67.40
- KXIN N/A
- 52 Week Low
- EVOK $1.94
- KXIN $0.15
- 52 Week High
- EVOK $10.86
- KXIN $2.50
- Technical
- Relative Strength Index (RSI)
- EVOK 84.40
- KXIN 30.42
- Support Level
- EVOK $10.66
- KXIN $0.15
- Resistance Level
- EVOK $10.75
- KXIN $0.22
- Average True Range (ATR)
- EVOK 0.06
- KXIN 0.28
- MACD
- EVOK -0.08
- KXIN -0.11
- Stochastic Oscillator
- EVOK 78.26
- KXIN 2.98
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.